



Stockholm, February 22(nd), 2016

Karin Bernadotte, board member and primary insider in ContextVision AB, has on
February 19(th), 2016 purchased 3 500 shares in ContextVision AB at a price of
NOK 28,00 per share. Following this transaction, Karin Bernadotte owns 6 500
shares in ContextVision AB.


"The company is in an extremely interesting phase, and I feel very confident
about the ongoing research and the future for ContextVision" comments Karin
Bernadotte.


For inquires please contact CEO Anita Tollstadius;
anita.tollstadius@contextvision.se

This information is subject to the disclosure requirements pursuant to the
Norwegian Securities Trading Act.


About ContextVision
ContextVision's cutting-edge technology helps doctors more accurately interpret
medical images, a crucial foundation for better diagnosis and treatment. An
industry pioneer for more than 30 years, the company's state-of-the-art medical
image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and
Mammography is used by leading equipment manufacturers worldwide. ContextVision
continues to invest heavily in R&D in order to expand its technology platform.
ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the
ticker COV. For more information, please visit www.contextvision.com.




[HUG#1987979] 
    